S. Todd

发表

Trends in Incidence and Mortality Rates of Uterine Cancer in Kentucky

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2021, Southern medical journal.

Cervical cancer incidence and mortality rates in Kentucky.

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2020, Gynecologic oncology.

Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute‐Comprehensive Cancer Center

B. Fridley, R. Wenham, S. Vadaparampil, 2020, Clinical genetics.

Vaginal cuff brachytherapy: do we need to treat to more than a two-centimeter active length?

D. Metzinger, M. El-Ghamry, P. Barry, 2021, Journal of contemporary brachytherapy.

Expression of the BAD pathway is a marker of triple-negative status and poor outcome

J. Lancaster, H. Park, M. Pena, 2019, Scientific Reports.

The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation.

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2020, Brachytherapy.

Dual antibiotic prevention bundle is associated with decreased surgical site infections

D. Boulware, S. Apte, R. Vargas, 2020, International Journal of Gynecological Cancer.

Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer.

R. Wenham, H. Chon, Jongphil Kim, 2021, Gynecologic oncology.

Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy

D. Metzinger, J. Gaskins, H. Eldredge-Hindy, 2021, International Journal of Gynecological Cancer.

Bilateral adnexal masses: A case report of acute myeloid leukemia presenting with myeloid sarcoma of the ovary and review of literature

D. Metzinger, S. Vranić, S. Al-Quran, 2023, Gynecologic oncology reports.